Premium
Elimination of circulatory IGM anti‐HSA precedes anti‐HBe seroconversion in patients with CAH type B
Author(s) -
Hellström U. B.,
Sylvan S. P. E.
Publication year - 1989
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.1890290110
Subject(s) - seroconversion , antibody , antigen , immunology , titer , immunoglobulin m , virology , human serum albumin , medicine , immunoglobulin g , biology , biochemistry
The presence of IgM and IgA antibodies with specificity for human serum albumin (HSA) were consecutively analyzed in serum samples from four patients with biopsy verified CAH type B during seroconversion in the HBe/anti‐HBe antigen system. Circulatory IgM anti‐HSA antibodies were present during HBe antigenemia. The antibody titers fluctuated, decreased, and were finally lost from the circulation. After the disappearance of IgM anti‐HSA antibodies, seroconversion to anti‐HBe reactivity occurred and a quiescent phase of the disease was established, as judged by normalization of transaminases and absence of circulatory HBV‐DNA. IgA anti‐HSA antibodies persisted in the circulation after the elimination of IgM anti‐HSA and seroconversion to anti‐HBe reactivity. For one of the patients, a dramatic increase in titers was followed by elimination of IgA anti‐HSA and seroconversion to anti‐HBs. The data indicate that the host “self”‐component HSA, when associated with “foreign” HBe or HBs antigenic structures, elicit immune responses to HSA, preventing the adequate development of anti‐HBe and anti‐HBs. The cessation of anti‐HSA reactivity, however, seemed to permit subsequent sensitization to HBe and HBs antigenic determinants, as detected by the presence of circulatory antibodies.